Bioventix Plc Notice of Results and Notice of AGM

 
TIDMBVXP 
 
Bioventix plc 
 
                        ("Bioventix" or "the Company") 
 
                      Notice of Results and Notice of AGM 
 
 
Bioventix plc (BVXP), a UK company specialising in the development and 
commercial supply of high-affinity monoclonal antibodies for applications in 
clinical diagnostics, announces that it will release its preliminary results 
for the year ended 30 June 2018 on 8 October 2018. 
 
The Company's Annual General Meeting will be held on Thursday 6 December at 
2.00p.m at Farnham Castle, Castle Street, Farnham, Surrey, GU9 0AG. 
 
 
For further information please contact: 
 
Bioventix plc                                           Tel: 01252 728 001 
Peter Harrison              Chief Executive Officer 
 
finnCap Ltd                                             Tel: 020 7220 0500 
Geoff Nash/Simon Hicks      Corporate Finance 
Alice Lane                  ECM 
 
 
About Bioventix plc: 
 
Bioventix (www.bioventix.com) specialises in the development and commercial 
supply of high-affinity monoclonal antibodies with a primary focus on their 
application in clinical diagnostics, such as in automated immunoassays used in 
blood testing. The antibodies created at Bioventix are generated in sheep and 
are of particular benefit where the target is present at low concentration and 
where conventional monoclonal or polyclonal antibodies have failed to produce a 
suitable reagent. Bioventix currently offers a portfolio of antibodies to 
customers for both commercial use and R&D purposes, for the diagnosis or 
monitoring of a broad range of conditions, including heart disease, cancer, 
fertility, thyroid function and drug abuse. Bioventix currently supplies 
antibody products and services to the majority of multinational clinical 
diagnostics companies. Bioventix is based in Farnham, UK and its shares are 
traded on AIM under the symbol BVXP. 
 
 
 
END

(END) Dow Jones Newswires

September 03, 2018 03:44 ET (07:44 GMT)

Bioventix (AQSE:BVXP.GB)
Historical Stock Chart
From Jan 2025 to Feb 2025